1-3 of 3
Donna Edwards
Close
Sort by
Journal Articles

E2F1 Is a Biomarker of Selinexor Resistance in Relapsed/Refractory Multiple Myeloma Patients

Alessandro Lagana, PhD, Seongjee Park, Donna Edwards, Violetta Leshchenko, PhD, Marsha Crochiere, Yosef Landesman, PhD, David Melnekoff, BS,MS, Itai Beno, PhD, Deepak Perumal, PhD, Deepu Madduri, MD, Joshua Richter, Ajai Chari, MD, Hearn Jay Cho, MD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3216.
https://doi.org/10.1182/blood-2018-99-116500
Published: 2018
Journal Articles

SOX11 augments BCR signaling to drive MCL-like tumor development

Pei-Yu Kuo, Shashidhar S. Jatiani, Adeeb H. Rahman, Donna Edwards, Zewei Jiang, Katya Ahr, Deepak Perumal, Violetta V. Leshchenko, Joshua Brody, Rita Shaknovich, B. Hilda Ye, Samir Parekh
Journal: Blood
Blood (2018) 131 (20): 2247–2255.
https://doi.org/10.1182/blood-2018-02-832535
Published: 2018
Includes: Supplemental data
Journal Articles

Patient-Tailored Mouse Genome Editing Recapitulates Hematopoietic and Systemic Manifestations of Barth Syndrome

Donna Edwards, PhD, Elizabeth Sierra Potchanant, PhD, Xinxin Huang, PhD, Zejin Sun, PhD, Maegan Capitano, PhD, Caroline Miller, Ying He, Hal E. Broxmeyer, PhD, Grzegorz Nalepa, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 775.
https://doi.org/10.1182/blood.V130.Suppl_1.775.775
Published: 2017